CEO Interviews

CEOLIVE Interviews CEO’s & Executives from publicly traded companies and start-ups.

Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
30 Apr
2019
Written by Mike Elliott

Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials »

In this episode of CEO Roadshow, we’re joined again by Mr. Thomas Equels, CEO of Hemispherx Biopharma, an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology.

Read more...
Which ESports Stocks You Should Be Watching and Why?
1 Apr
2019
Written by Mike Elliott

Which ESports Stocks You Should Be Watching and Why? »

Esports is entering a tremendous growth phase. The global esports economy is expected to grow to more than $905 million this year, according to market research firm Newzoo. That figure would represent year-over-year growth of roughly 38%.

Read more...
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
14 Dec
2018
Written by Mike Elliott

BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate »

BriaCell is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer.

Read more...
Citius Pharma (CTXR) Chairman, Leonard Mazur Discusses Progress and Timeline for Phase 3 Trial
11 Dec
2018
Written by Mike Elliott

Citius Pharma (CTXR) Chairman, Leonard Mazur Discusses Progress and Timeline for Phase 3 Trial »

Citius is a specialty pharmaceutical company dedicated to the development and commercialization of unique therapeutic products in adjunctive cancer care with a focus on infectious diseases.

Read more...
Precision Therapeutics (AIPT) Bringing AI to Precision Medicine
10 Dec
2018
Written by Mike Elliott

Precision Therapeutics (AIPT) Bringing AI to Precision Medicine »

Precision Therapeutics (AIPT) operates in two business areas: first, applying artificial intelligence to personalized medicine and drug discovery to provide personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal.

Read more...
Pacific Green Technologies (PGTK) Closes Additional $79.6 Million in Commercial Retrofits
7 Dec
2018
Written by Mike Elliott

Pacific Green Technologies (PGTK) Closes Additional $79.6 Million in Commercial Retrofits »

Pacific Green Technologies Inc. (PGTK), owner of the ENVI-MarineTM Exhaust Gas Scrubbing System (System), has just announced that its wholly owned subsidiary, Pacific Green Marine Technologies Inc. (PGMT), has executed an agreement to manufacture its System for 52 vessels owned or managed by SCORPIO TANKERS INC. (STNG) (Agreements).

Read more...

Login

Lost your password?